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Abstract
Purpose It is difficult for clinicians to inform patients
about the success rate of a treatment as a cervical anterior
discectomy procedure. Ideally, a proportion of good out-
come as rated by patients is known. Patient-reported out-
come measurements are helpful. The purpose is to relate
the difference in Neck Disability Index (NDI) after a cer-
vical anterior discectomy procedure for single level cer-
vical degenerative disc disease with the patients’ rating of
their actual clinical situation after long-term follow-up to
define the substantial clinical benefit (SCB).
Methods After completion of the NDI, patients who were
surgically treated for cervical single level degenerative
disease were asked to complete a five-item Likert scale to
rate their clinical situation. After dichotomisation of the
outcome in good versus less than good, a cut-off value was
defined by determining the value of the difference of NDI
with the highest specificity and sensitivity. Funding was
not obtained.
Results SCB for NDI after surgery for cervical single level
degenerative disease should be set at ten with area under
the curve (AUC) of 0.71 for sensitivity as well specificity.
Conclusions The goal for each treatment is a good out-
come. While comparing treatments for cervical degenera-
tive disc disease only those with an SCB of ten will be
relevant for the patient, as patients who achieved this dif-
ference in NDI rated their actual situation at long-term
follow-up as good.
Keywords Anterior cervical discectomy  NDI  PROM 
Substantial clinical benefit  SCB  Outcome
Introduction
Minimal clinically important difference (MCID) has been
introduced to incorporate clinical relevance in the inter-
pretation of the results of clinical trials. Originally, it was
defined as ‘‘the smallest difference in score in the domain
of interest which patients perceive as beneficial and would
mandate, in the absence of troublesome side effects and
excessive cost, a change in the patient’s management’’ [1].
Although different methods to estimate MCID have
been described [2], they are all constructed from a
researcher’s point of view. If patients are involved, they
rate their outcome according to predefined terms and rel-
ative to their pre-treatment situation. Statements such as
much better, somewhat better, about the same, somewhat
worse and much worse are used for the comparison of
patient’s ratings and clinical outcome to estimate MCID.
& Ronald H. M. A. Bartels
ronald.bartels@radboudumc.nl
1 Department of Orthopaedic Surgery, Via Sana Clinics,
Hoogveldseweg 1, 5451 AA Mill, The Netherlands
2 Department of Health Evidence, Radboud University
Medical Center, Geert Groote Plein-zuid 10,
6525 GA Nijmegen, The Netherlands
3 Department of Neurology, Canisius Wilhelmina Hospital,
Weg door Jonkerbos 100, 6532 SZ Nijmegen, The
Netherlands
4 Department of Orthopaedic Surgery, Radboud University
Medical Center, Geert Groote Plein-zuid 10,
6525 GA Nijmegen, The Netherlands
5 Department of Neurosurgery, Radboud University Medical
Center, Geert Groote Plein-zuid 10, 6525 GA Nijmegen, The
Netherlands
6 Department of Neurosurgery, Canisius Wilhelmina Hospital,
Weg door Jonkerbos 100, 6532 SZ Nijmegen, The
Netherlands
123
Eur Spine J (2018) 27:1262–1265
https://doi.org/10.1007/s00586-017-5260-y
MCID is associated with the clinical outcome related to the
statement somewhat better than the pre-treatment situation.
A newer concept is the substantial clinical benefit
(SCB). It was originally described for patients who were
surgically treated for lumbar degenerative disease and
defined as clinical improvement that represented a sub-
stantial clinical benefit after treatment [3]. The method was
similar to some of those used for constructing MCID [2].
The patients rated their situation compared to the situation
1 year before [3].
The Neck Disability Index (NDI) is a frequently used
outcome measurement to evaluate the treatment of neck-
related disorders such as whiplash-associated disorder or
degenerative disc disease. The MCID for NDI has been
determined as 7.5 on a 0–50 scale by distinguishing ‘‘much
better’’ from ‘‘somewhat better’’ patients [4]. SCB was set
at 9.5 [4].
However, all parties involved want to have a good
outcome after a treatment, also after long-term follow-up.
Patients with severe neck and/or arm pain primarily opted
for treatment not to achieve some improvement of their
pre-treatment clinical situation, but to obtain a good clin-
ical result at the end. In support of this hypothesis, a recent
study on lumbar arthroplasty also focused on clinically
relevant and long-lasting reduction of pain [5]. We were
interested in the clinical outcome after a surgical treatment
for degenerative cervical disc disease defined by the dif-
ference of the pre- and postoperative NDI (DNDI) and the
patients’ ratings of their clinical situation after long-term
follow-up. Ratings were not based on a comparison with
their pre-treatment situation.
Methods
The STROBE statement was adhered to [6]. The ethical
board CMO Arnhem-Nijmegen approved the study. The
study has been carried out in accordance with the World
Medical Association Declaration of Helsinki [7].
Patients who participated in the Procon trial (Current
Controlled Trials ISRCTN41681847) [8], a comparison of
different anterior cervical surgery techniques for symp-
tomatic single level degenerative disc herniation without
spinal cord involvement, and who completed an NDI were
eligible. Since treatments were not compared, the patients
should be considered as part of a cohort.
The design of the trial from which the sample of the
current was taken, was a prospective, double-blind, single-
center randomized study with a three-arm parallel group
design. Adult patients suffering from radicular signs and
symptoms due to single level degenerative disc disease
were included after informed consent. The experimental
group was anterior cervical discectomy with arthroplasty,
whereas anterior cervical discectomy with fusion by cage
standalone and anterior cervical discectomy were control
groups. The primary outcome was NDI. The last follow-up
after the index surgery was at the end of 2015. At that
moment, the patients were asked to complete the NDI.
Within 2 months after completion of the NDI, a ques-
tionnaire was sent to the patients about the qualification of
their clinical situation regarding the neck pain and arm pain
at that moment.
For this questionnaire, a five-item Likert scale was used.
We did not predefine the criteria, since we were interested
in the qualitative judgment of the patients without any bias
introduced by the researcher. The possible qualifications of
their current clinical situation were: excellent, very good,
good, moderate, and bad.
SAS version 9.2 (SAS Institute Inc. Cary NC, USA) was
used for the statistical analysis. Continuous variables were
depicted as mean value ± standard deviation (minimum–
maximum). For data analysis the Student’s t test was used.
At dichotomisation of outcome, two groups of patients
could be defined: those with a good to excellent outcome,
and those with a less than good outcome [9]. To estimate
the value of DNDI that corresponded best with the
dichotomised outcome, the cut-off values with the highest
sensitivity and specificity were chosen separately. A
P value\0.05 was assumed to be statistically significant.
Results
Of the 140 patients in the trial, 80 patients (57.1%) were
eligible. Women outnumbered men (61 versus 53); the
mean age was 45.3 ± 6.8 (29–49). Follow-up after the
index surgery was 9.1 ± 1.9 years (5.6–12.2 years). At
that time patients completed the NDI. The mean preoper-
ative NDI was 18.6 ± 7.1 (1–36), whereas the mean
postoperative NDI at the last follow-up was 7.17 ± 8.3
(0–29).
Eight patients rated their outcome as excellent, 23 as
very good, 28 as good, 17 as moderate and 4 as bad.
To detect the optimal cut-off value for the DNDI, a
graph was constructed showing sensitivity and specificity
as a function of all possible cut-off values (Fig. 1). The
highest sensitivity and highest specificity (both 71.0%) for
a good outcome were observed if DNDI = 10.
Discussion
Minimal clinically important difference (MCID) has been
introduced in medical literature to define a threshold of
improvement that is clinically important for relativizing the
statistically significant differences. However, patients are
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not expecting a minimal improvement, but are awaiting an
optimal result.
Therefore, MCID is an important demarcation, but it
could be considered a floor value rather than a goal in
defining clinical success.
Although estimates for MCID and SCB for NDI have
been made, the major drawback is the comparison of the
patient’s clinical situation with an earlier situation. Of
course patients are generally interested in the improvement
of their pre-treatment clinical state, but they are even more
interested in the actual clinical situation at longer-term fol-
low-up. A questionnaire sent to participants to prepare for a
conference on MCID in 2001 revealed that 84% agreed that
MCID should be validated for long-term outcome [10].
For two reasons, this study is unique. First it correlates
the patients’ ratings of their actual clinical situation and not
in comparison to their pre-treatment situation. A good
outcome is the preoperative goal for patients as well as
treating physicians. Secondly, the outcome was rated a
long time after the surgery. As far as we know, this has
never been done before.
Therefore, SCB for NDI after long-term follow-up for
cervical anterior discectomy is set at 10. This resembles the
value of 9.5 reported by Carreon who compared the
judgement of the actual situation compared to the preop-
erative situation [4]. Follow-up was shorter.
As Glassman has already pointed out, MCID is a floor
value, and nobody goes for the minimal result. Nowadays,
the implementation of treatments that only provide a
minimal clinically important difference cannot be justified.
A good outcome should be the goal.
Therefore, the value of MCID and SCB should be
reconsidered. Although MCID was essential for the
awareness that statistical results should also be translated
into clinical relevance, nowadays only good outcomes are
acceptable even though a good outcome for 100% of
patients is impossible. We suggest focusing only on SCB to
compare the two treatments.
However, the optimal relative difference in SCB
between groups should still be defined. To evaluate a new
treatment, the clinical result is compared to a known
treatment, which serves as the gold standard. If the out-
come of the new treatment compared to the pre-treatment
situation is equal to the MCID and is similar to that of the
gold standard, then an equal effect might be assumed. The
same holds true for SCB. If a treatment is better than the
old one, it cannot be expected that the clinical difference in
treatment is equal to at least the absolute value of MCID or
SCB. In our opinion, defining a minimum difference in the
percentage of patients reaching SCB is a reasonable for
making a comparison of the superiority or similarity of a
treatment’s efficacy. This value is best established by a
worldwide board of physicians, representatives of insur-
ance companies, governments and, most importantly,
patients as consumers of healthcare.
The terms used to qualify the actual situation were not
predefined. This can be interpreted as a flaw. However, we
were reluctant to specify criteria due to the risk of a
researcher-guided system and the subjective character of
the rating being restricted so that it did not represent the
patient’s perspective. We feel confident that the chosen
strategy contributed to a qualification that best resembled
Fig. 1 Sensitivity and
specificity as function from
chosen boundary of delta NDI
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the patient’s subjective interpretation of the situation at that
moment.
The different techniques for cervical anterior discec-
tomy might be viewed s a drawback. However, the patients
were randomized after the NDI was established. Therefore,
the patient’s rating was not influenced by knowing whether
an implant was used and, if so, which type.
Retrieving information from less than 100% of the
patients included in the trial from which the sample for this
study was taken could be interpreted as a flaw. However,
since the goal of the study was to establish the threshold for
SCB for NDI, the outcome of interest should be related to
the qualification of patients. For this purpose only a cohort
of patients is needed, and therefore, we do not think that the
chosen policy will alter the conclusion.
We did not take into account mental distress. Recently,
it has been shown that patients with a high preoperative
level of anxiety or depression showed at baseline but also
at 2 years follow-up a worse outcome in NDI [11].
Therefore, SCB was not examined in cases without mental
distress. Although SCB in this group will probably be
lower, we think that the calculated SCB for NDI from our
study will be more representative in general practice. Not
every individual is currently screened for anxiety level.
Furthermore, for the individual, it will not be possible to
exactly determine SCB based on a score from an individual
test for anxiety level.
Finally, determining the cut-off values of DNDI in
relation to a dichotomised outcome as good or less good is
questionable. We chose a conservative approach by
requesting the highest sensitivity in combination with the
highest specificity. Increasing the values of DNDI would
increase sensitivity and decrease specificity, and decreasing
the values of DNDI would induce a reversal effect. This
would result, in our opinion, in a less distinct cut-off value
for DNDI in relation to a good and a less good outcome.
In conclusion, a difference of ten between preoperative
and postoperative NDI after a cervical anterior discectomy
procedure for single level cervical degenerative disease
corresponds to a clinical situation that patients rate as good
at long-term follow-up. Reporting the proportion of
patients with a good outcome will help to choose a
treatment.
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